UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Treating viral hepatitis C: efficacy, side effects, and complications

Gut, 2006-09, Vol.55 (9), p.1350-1359

2006

Volltextzugriff (PDF)

Transient autoimmune hepatitis induced by a thymoma

The American journal of gastroenterology, 2009-05, Vol.104 (5), p.1332-1334

2009

Volltextzugriff (PDF)

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

Alimentary pharmacology & therapeutics, 2018-02, Vol.47 (4), p.516-525

2018

Volltextzugriff (PDF)

Improvement of liver function parameters in advanced HCV‐associated liver cirrhosis by IFN‐free antiviral therapies

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (7), p.889-901

2015

Volltextzugriff (PDF)

Chronic Hepatitis E in Heart Transplant Recipients

American journal of transplantation, 2012-11, Vol.12 (11), p.3128-3133

2012

Volltextzugriff (PDF)

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.115-126

2017

Volltextzugriff (PDF)

2-Acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of Cyclin E expression

Oncogene, 1999-11, Vol.18 (47), p.6443-6453

1999

Volltextzugriff (PDF)

Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (3), p.270-280

2018

Volltextzugriff (PDF)

Molecular therapy for the treatment of hepatocellular carcinoma

British journal of cancer, 2009-01, Vol.100 (1), p.19-23

2009

Volltextzugriff (PDF)

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

British journal of cancer, 2005-05, Vol.92 (10), p.1862-1868

2005

Volltextzugriff (PDF)

Developmental aspects of human hepatic drug glucuronidation in young children and adults

Gut, 2002-02, Vol.50 (2), p.259-265

2002

Volltextzugriff (PDF)

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir

Alimentary pharmacology & therapeutics, 2014-01, Vol.39 (1), p.85-92

2014

Volltextzugriff (PDF)

Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome

Endoscopy, 2012-11, Vol.44 (11), p.1055-1058

2012

Volltextzugriff (PDF)

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

Alimentary pharmacology & therapeutics, 2013-12, Vol.38 (11-12), p.1365-1372

2013

Volltextzugriff (PDF)

Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?

HIV medicine, 2018-04, Vol.19 (4), p.299-307

2018

Volltextzugriff (PDF)

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC‐Specific Chimeric Antigen Receptor

American journal of transplantation, 2017-04, Vol.17 (4), p.917-930

2017

Volltextzugriff (PDF)

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

Journal of viral hepatitis, 2012-08, Vol.19 (8), p.537-546

2012

Volltextzugriff (PDF)

Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts

American journal of transplantation, 2012-12, Vol.12 (12), p.3425-3436

2012

Volltextzugriff (PDF)

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study

Alimentary pharmacology & therapeutics, 2005-08, Vol.22 (3), p.227-232

2005

Volltextzugriff (PDF)

Interleukin 6 and liver regeneration

Gut, 2000-08, Vol.47 (2), p.309-312

2000

Volltextzugriff (PDF)

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation

Transplant infectious disease, 2016-06, Vol.18 (3), p.326-332

2016

Volltextzugriff (PDF)

The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma

Annals of oncology, 2016-08, Vol.27 (8), p.1467-1474

2016

Volltextzugriff (PDF)

Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake

Gut, 2005-11, Vol.54 (11), p.1590-1596

2005

Volltextzugriff (PDF)

Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract

Gut, 2006-04, Vol.55 (4), p.498-504

2006

Volltextzugriff (PDF)

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Journal of hepatology, 2017-09, Vol.67 (3), p.549-558

2017

Volltextzugriff (PDF)

1 – 25 von 2.604

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.146)
Mit Volltextzugriff
(1.664)

Publikationsform

Artikel
(1.971)
Tagungsberichte
(467)
Buchkapitel
(140)
Bücher
(19)
Berichte
(5)
Reviews
(1)
Texte
(1)

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.168)
Humans
(1.133)
Life Sciences & Biomedicine
(1.112)
Female
(577)
Male
(572)
Biological And Medical Sciences
(476)
Gastroenterology & Hepatology
(451)
Medical Sciences
(447)
Adult
(424)
Middle Aged
(417)
Aged
(267)
Adolescent
(168)
Infectious Diseases
(166)
Animals
(159)
Gastroenterology. Liver. Pancreas. Abdomen
(154)
General & Internal Medicine
(139)
Treatment Outcome
(132)
Medicine, General & Internal
(124)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(114)
Immunology
(113)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.217)
IngentaConnect
(1.106)
Journals@Ovid
(942)
Thieme - Connect here FIRST to enable access
(747)
Free E-Journal (出版社公開部分のみ）
(620)
Elsevier ScienceDirect Journals Complete
(465)
Wiley Online Library
(408)
Single Journals
(340)
Wiley Online Library
(339)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(326)
IngentaConnect Journals
(313)
Springer Online Journals
(267)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(230)
eBooks on EBSCOhost
(148)
Ebook Central Perpetual and DDA
(143)
Nature_系列刊
(72)
BMJ
(63)
Oxford Journals
(56)
BMJ Journals Archiv - DFG Nationallizenzen
(49)
Oxford Journals 2020 Medicine
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Zeitschrift Für Gastroenterologie
(182)
Journal Of Hepatology
(177)
Der Internist
(149)
Hepatology
(99)
Gastroenterology
(73)
Deutsche Medizinische Wochenschrift
(70)
Gut
(43)
Journal Of Viral Hepatitis
(41)
The American Journal Of Gastroenterology
(24)
Liver International
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Treating viral hepatitis C: efficacy, side effects, and complications

Transient autoimmune hepatitis induced by a thymoma

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

Improvement of liver function parameters in advanced HCV‐associated liver cirrhosis by IFN‐free antiviral therapies

Chronic Hepatitis E in Heart Transplant Recipients

All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database

2-Acetaminofluorene blocks cell cycle progression after hepatectomy by p21 induction and lack of Cyclin E expression

Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection

Molecular therapy for the treatment of hepatocellular carcinoma

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients

Developmental aspects of human hepatic drug glucuronidation in young children and adults

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir

Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome

The clinical significance of drug–drug interactions in the era of direct‐acting anti‐viral agents against chronic hepatitis C

Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC‐Specific Chimeric Antigen Receptor

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

Enrichment of Regulatory T Cells in Acutely Rejected Human Liver Allografts

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study

Interleukin 6 and liver regeneration

Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation

The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma

Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake

Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract

norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

Suchergebnisse filtern